CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 214 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $773 | +2660.7% | 28,405 | +2145.5% | 0.00% | – |
| Q2 2023 | $28 | -47.2% | 1,265 | -52.4% | 0.00% | – |
| Q4 2022 | $53 | -99.9% | 2,657 | +13.7% | 0.00% | – |
| Q3 2022 | $59,000 | -1.7% | 2,336 | -7.7% | 0.00% | – |
| Q2 2022 | $60,000 | +2900.0% | 2,530 | +2286.8% | 0.00% | – |
| Q1 2022 | $2,000 | -97.0% | 106 | -96.9% | 0.00% | – |
| Q4 2021 | $66,000 | -94.8% | 3,369 | -94.8% | 0.00% | -100.0% |
| Q3 2021 | $1,274,000 | +1669.4% | 64,787 | +1865.0% | 0.00% | – |
| Q2 2021 | $72,000 | -7.7% | 3,297 | 0.0% | 0.00% | – |
| Q1 2021 | $78,000 | -9.3% | 3,297 | 0.0% | 0.00% | – |
| Q4 2020 | $86,000 | +22.9% | 3,297 | -18.6% | 0.00% | – |
| Q3 2020 | $70,000 | +133.3% | 4,050 | +121.9% | 0.00% | – |
| Q2 2020 | $30,000 | -42.3% | 1,825 | -58.7% | 0.00% | – |
| Q1 2020 | $52,000 | +1633.3% | 4,417 | +1673.9% | 0.00% | – |
| Q4 2019 | $3,000 | -99.0% | 249 | -98.6% | 0.00% | -100.0% |
| Q4 2017 | $314,000 | – | 17,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |